Rita Peters (Editorial Director, Pharmaceutical Technology)
David Lyon, Ph.D. (Director, Research, Lonza Pharma and Biotech)
Ronak Savla (Pharm.D., Ph.D. Scientific Affairs Manager , Catalent Pharma Solutions)
Therapies will not produce the expected outcomes if patients do not take drugs according to the prescribed method. The World Health Organization has identified factors that drive patient non-adherence to drug regimens: social, economic and behavioral factors; disease or condition-related factors; health system-related factors; and the patient’s experience with the drug.
These external factors contribute to the already complex task of formulating safe and effective drugs that also facilitate a patient’s ability and desire to take medications as prescribed. Formulation methods, new dosage forms, excipients, and technologies can enable drug developers to design drugs that encourage adherence to drug regimens by different patient groups.
In this session, formulation experts will discuss roadblocks to patient adherence, and technologies and processes that can be employed to mitigate these problems.